Takeda Pharmaceutical Co Ltd

Bank of New York Mellon Corp TAK

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/10/2026

Shares

111,154

Value ($000)

1,733

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/10/2026	1,733	0.0%	111,154	12/31/2025
2025 Q3	11/3/2025	1,898	0.0%	129,669	9/30/2025
2025 Q2	8/5/2025	2,176	0.0%	140,755	6/30/2025
2025 Q1	4/29/2025	1,925	0.0%	129,479	3/31/2025
2024 Q4	2/4/2025	1,389	0.0%	104,892	12/31/2024
2024 Q3	11/12/2024	1,273	0.0%	89,504	9/30/2024
2024 Q2	7/25/2024	1,159	0.0%	89,534	6/30/2024
2024 Q1	4/25/2024	1,546	0.0%	111,269	3/31/2024
2023 Q4	1/29/2024	1,717	0.0%	120,296	12/31/2023
2023 Q3	10/24/2023	2,121	0.0%	137,093	9/30/2023
2023 Q2	8/3/2023	2,214	0.0%	140,934	6/30/2023
2023 Q1	5/9/2023	2,474	0.0%	150,120	3/31/2023
2022 Q4	2/14/2023	2,197	0.0%	140,822	12/31/2022
2022 Q3	11/14/2022	1,294	0.0%	99,718	9/30/2022
2022 Q2	8/15/2022	1,003	0.0%	71,445	6/30/2022
2022 Q1	5/11/2022	914	0.0%	63,801	3/31/2022
2021 Q4	2/11/2022	689	0.0%	50,596	12/31/2021
2021 Q3	11/18/2021	1,002	0.0%	61,166	9/30/2021
2021 Q2	8/11/2021	1,115	0.0%	66,248	6/30/2021
2021 Q1	5/13/2021	1,190	0.0%	65,191	3/31/2021
2020 Q4	2/9/2021	1,496	0.0%	82,173	12/31/2020
2020 Q3	11/12/2020	1,531	0.0%	85,840	9/30/2020
2020 Q2	8/12/2020	1,971	0.0%	109,884	6/30/2020
2020 Q1	5/6/2020	1,991	0.0%	131,195	3/31/2020
2019 Q4	2/14/2020	2,164	0.0%	109,701	12/31/2019